Jennifer Rachel Cochran

Affiliations: 
Bioengineering Stanford University, Palo Alto, CA 
Area:
Bioengineering
Website:
https://profiles.stanford.edu/jennifer-cochran
Google:
"Jennifer Rachel Cochran"
Bio:

https://books.google.com/books?id=k4gvAQAAIAAJ
https://kdw-lab.mit.edu/members/alumni/

Mean distance: 106866
 
Cross-listing: E-Tree

Parents

Sign in to add mentor
Lawrence J. Stern grad student 2001 MIT (Chemistry Tree)
 (The molecular mechanism of T cell activation investigated with class II MHC oligomers.)
K. Dane Wittrup post-doc 2002-2004 MIT (Chemistry Tree)
William F. DeGrado post-doc 2004-2005 UCSF (Chemistry Tree)

Children

Sign in to add trainee
Ping-Chuan (Christina) Tsai post-doc 2010-2012 Stanford Medical School (Chemistry Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kwan BH, Zhu EF, Tzeng A, et al. (2017) Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses. The Journal of Experimental Medicine
Kariolis MS, Miao YR, Diep A, et al. (2016) Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. The Journal of Clinical Investigation
Moynihan KD, Opel CF, Szeto GL, et al. (2016) Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses. Nature Medicine
Glasgow JE, Salit ML, Cochran JR. (2016) In Vivo Site-Specific Protein Tagging with Diverse Amines Using an Engineered Sortase Variant. Journal of the American Chemical Society
Currier NV, Ackerman SE, Kintzing JR, et al. (2016) Targeted Drug Delivery with an Integrin-Binding Knottin-Fc-MMAF Conjugate Produced by Cell-Free-Protein Synthesis. Molecular Cancer Therapeutics
Mitchell AC, Briquez PS, Hubbell JA, et al. (2015) Engineering growth factors for regenerative medicine applications. Acta Biomaterialia
Parke-Houben R, Fox CH, Zheng LL, et al. (2015) Interpenetrating polymer network hydrogel scaffolds for artificial cornea periphery. Journal of Materials Science. Materials in Medicine. 26: 107
Sonnenberg SB, Rane AA, Liu CJ, et al. (2015) Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction. Biomaterials. 45: 56-63
Liu CJ, Jones DS, Tsai PC, et al. (2014) An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist. Febs Letters. 588: 4831-7
Kariolis MS, Miao YR, Jones DS, et al. (2014) An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis. Nature Chemical Biology. 10: 977-83
See more...